Shares of Longevity Health Holdings Inc (NASDAQ:XAGE) surged on Tuesday afternoon following the announcement of its definitive merger agreement with plasma collection leader True Health Inc.
This merger builds on Longevity’s recent acquisitions of Carmell Therapeutics and Elevai Skincare, which have technologies that utilize plasma-derived growth factors and exosomes. THPlasma plays a role in addressing the U.S. shortfall of plasma-derived therapeutics.
CEO George Chi called the merger a “transformative step expected to supercharge our growth by unlocking access to public markets.”
XAGE Price Action: According to data from Benzinga Pro, Longevity Health shares closed Tuesday up 115.50% to $5.70. The stock has a 52-week high of $59.10 and a 52-week low of $2.20.
Read Also: Best Healthcare Stocks Right Now
How To Buy XAGE Stock
By now, you're likely curious about how to participate in the market for Longevity Health Holdings — be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.
In the case of Longevity Health Holdings, which is trading at $5.50 this afternoon, $100 would buy you 18.18 shares of stock.
Image: Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.

